MSN: Study finds cost of brand-name epilepsy drugs nearly triples in eight years
UC expert says generic drugs typically are a safe, effective alternative
A new study found the cost for a year's supply of brand-name epilepsy drugs increased by 277% from 2010 to 2018, while the cost for a year's supply of generic epilepsy drugs decreased by 42% over the same time period.
Michael Privitera, MD, professor of neurology in the University of Cincinnati College of Medicine and director of the Epilepsy Center at the UC Gardner Neuroscience Institute, commented on the study for an article published by United Press International and MSN.
Privitera said he and his colleagues have performed "rigorous studies" that found no clinically important differences between generic and name-brand versions of one anti-seizure medication, lamotrigine.
The main approach to lowering prices for patients is to use generic drugs whenever possible, Privitera said, but some patients' seizures are only controlled with particular drugs that do not have generic equivalents.
Read the MSN story, originally published by United Press International.
Featured photo at top courtesy of Unsplash.
Related Stories
UC student breaks world record in competitive speedcubing
December 19, 2025
UC computer science student Sujan Feist set a new world record in speedcubing at competition this month in Coshocton, Ohio. Feist is the reigning world champion in the 2x2 division.
A partnership to end pancreatic cancer
December 19, 2025
Since 2010, BSI Engineering has raised more than $1.2 million for pancreatic cancer research at the University of Cincinnati Cancer Center in honor of a friend and inspiration to BSI’s founders, Bryan Speicher.
Bazinga! UC physicist cracks ‘Big Bang Theory’ problem
December 19, 2025
A physicist at the University of Cincinnati and his colleagues figured out something two of America’s most famous fictional physicists couldn’t: theoretically how to produce subatomic particles called axions in fusion reactors.